fenoterol


Also found in: Wikipedia.

fenoterol

 [fen″o-ter´ol]
a beta2-adrenergic receptor agonist used as a bronchodilator for the treatment and prophylaxis of reversible bronchospasm; administered by inhalation as the hydrobromide salt.

fenoterol

[fen′ōter′ol]
a beta2-adrenergic receptor agonist used as a bronchodilator for the treatment and prophylaxis of reversible bronchospasm, administered by inhalation as the hydrobromide salt.

fenoterol

A beta2-agonist, adrenaline-like drug that is valuable in the management of asthma while having comparatively little effect on the heart. Its action is similar to that of SALBUTAMOL. It is produced in combination with the anticholinergic drug ipratropium bromide under the brand name Duovent.
Mentioned in ?
References in periodicals archive ?
Contract awarded for Fcia 2471 Fenoterol 500 Mcg / Ipratropium 250 Mcg / 2015
2]-agonist): salbutamol or fenoterol by metered-dose inhaler or nebulisation for lower-airway obstruction Inhaled nebulised adrenaline for upper-airway obstruction [H.
Effect of Bryophyllum pinnatum versus fenoterol on uterine contractility.
Maternal and fetal side effects of tocolysis using transdermal nitroglycerin or intravenous fenoterol combined with magnesium sulfate.
18) New Zealand suffered a further epidemic of asthma deaths between 1976 and the late 1980s, following the introduction of inhaled fenoterol, another potent nonspecific beta-agonist.
Propofol was added, 50 mg twice, and nebulised fenoterol bromhydrate 1.
salbutamol 400-800 [micro]g; terbutaline 500-1 000 [micro]g; fenoterol 200-400 [micro]g) and anticholinergic agents (ipratropium bromide 80 [micro]g) may be given by pressured metered dose inhaler and spacer, or by jet nebulisation (salbutamol 2.
Glendining S (1979): The use of Fenoterol (Berotec) respirator solution 0.
Pharmacodynamic Effects of Inhaled Dry Powder Formulations of Fenoterol and Colforsin in Asthma," Clin.
Effects of dopexamine in comparison with fenoterol on carbohydrate, fat and protein metabolism in healthy volunteers.
After the manufacturer of the asthma drug fenoterol sharply criticized an epidemiological study published in The Lancet concluding that the drug caused increased mortality in asthmatics, the author conducted a second study to meet the manufacturer's objections.